The clinical management of primary hypertension in adults
NCGC/NICE Clinical Guideline 1271

This Guideline was produced by the National Clinical Guideline Centre and commissioned by the National Institute for Health and Clinical Excellence1. It is a partial update of Clinical Guideline 18 (2004) and Clinical Guideline 34 (2006) on Essential Hypertension in adults1.

Recommendations for the use of CCBs

Offer Step 1 antihypertensive treatment with a CCB to people aged over 55 years and to black people of African or Caribbean family origin of any age1.
If therapy is initiated with a beta-blocker and a second drug is required, add a CCB rather than a thiazide-like diuretic to reduce the person’s risk of developing diabetes1.
If treatment with three drugs is required, the combination of ACE inhibitor or angiotensin-II receptor blocker, CCB and thiazide-like diuretic should be used1.

References

  1. National Institute of Clinical Excellence [Internet]. Available from: http://goo.gl/8fNRD. Accessed 2 February 2018.